These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Long-term administration of tyquanol in the treatment of patients with ischemic heart disease in combination with hyperlipidemia].
    Author: Panchenko VM, Ershov AA, Isaev VA.
    Journal: Klin Med (Mosk); 2003; 81(3):40-2. PubMed ID: 12698850.
    Abstract:
    33 patients with coronary heart disease and hyperlipidemia took tyquanol for 6 months. Tyquanol is a complex of biologically active substances represented by polyunsaturated fatty acids, antioxidants and polyvitamins produced of dietary oils of the sea and plant origin. As a result of the treatment with tyquanol cholesterol, beta-lipoproteins, triglycerides lowered by 16.1, 11.1, 26.3%, respectively. Alphipoproteins rose by 8.8%. A negative effect on hepatic, renal functions or electrolyte composition was not observed.
    [Abstract] [Full Text] [Related] [New Search]